Paul Edward Walker

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Edward Walker:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7,692,298 $146,153,662 $19 28 Jun 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24,471,264 $108,897,125 $4.45 17 Jul 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1,090,793 $61,084,408 $56 22 Apr 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3,614,486 $38,638,855 $10.69 16 Sep 2024 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 948,948 $1,916,875 $2.02 11 Apr 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2,563,257 $1,204,731 $0.47 22 Dec 2021 Indirect
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 114 $3,196 $28.04 13 Jun 2023 Indirect
Allakos Inc. Director Common Stock 0 $0 $0.32 15 May 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 02 Oct 2025 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3,000,000 11 Apr 2022 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.5 30 Nov 2022 Indirect
Allakos Inc. Director Stock Option (right to buy) 0 15 May 2025 Direct
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 25 May 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 28 Jun 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 02 Oct 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 02 Oct 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 02 Oct 2025 Indirect
Trillium Therapeutics Inc. Director Common Shares 0 17 Nov 2021 Indirect
Trillium Therapeutics Inc. Director Series II Non-Voting Convertible First Preferred Shares 0 17 Nov 2021 Indirect
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct
Trillium Therapeutics Inc. Director Warrant to Purchase Common Shares 0 17 Nov 2021 Indirect
Trillium Therapeutics Inc. Director Warrant to Purchase Series II Preferred Shares 0 17 Nov 2021 Indirect

Insider Reports Filed by Paul Edward Walker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NEUE NeueHealth, Inc. 02 Oct 2025 31 $14.00 4 Director, 10%+ Owner 06 Oct 2025, 17:53
ALLK Allakos Inc. 15 May 2025 9 $0 4 Director 15 May 2025, 16:28
NEUE NeueHealth, Inc. 01 Oct 2024 3 $0 4 10%+ Owner 03 Oct 2024, 18:34
MBX MBX Biosciences, Inc. 16 Sep 2024 5 $8,000,000 4 10%+ Owner 17 Sep 2024, 20:18
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 12 Sep 2024, 19:36
ALLK Allakos Inc. 24 May 2024 1 $0 4 Director 29 May 2024, 20:13
KRRO Korro Bio, Inc. 22 Apr 2024 1 $999,992 4 10%+ Owner 24 Apr 2024, 17:00
NEUE NeueHealth, Inc. 08 Apr 2024 3 $0 4 10%+ Owner 10 Apr 2024, 19:28
BHG Bright Health Group Inc. 19 Dec 2023 1 $0 4 10%+ Owner 21 Dec 2023, 17:04
FREQ Korro Bio, Inc. 03 Nov 2023 0 $0 3 10%+ Owner 07 Nov 2023, 21:33
BHG Bright Health Group Inc. 31 Oct 2023 1 $0 4 10%+ Owner 02 Nov 2023, 18:54
BHG Bright Health Group Inc. 15 Sep 2023 1 $0 4 10%+ Owner 19 Sep 2023, 18:29
BHG Bright Health Group Inc. 11 Aug 2023 1 $0 4 10%+ Owner 16 Aug 2023, 08:58
SVRA Savara Inc 17 Jul 2023 1 $999,999 4 10%+ Owner 19 Jul 2023, 19:12
MIRM Mirum Pharmaceuticals, Inc. 13 Jun 2023 4 $0 4 10%+ Owner 15 Jun 2023, 16:36
ALLK Allakos Inc. 25 May 2023 1 $0 4 Director 30 May 2023, 18:32
AKUS Akouos, Inc. 30 Nov 2022 1 $0 4 10%+ Owner 02 Dec 2022, 16:13
BHG Bright Health Group Inc. 17 Oct 2022 2 $137,700,000 4 10%+ Owner 19 Oct 2022, 20:03
ALLK Allakos Inc. 21 Sep 2022 2 $19,999,680 4 Director 23 Sep 2022, 16:35
ALLK Allakos Inc. 25 May 2022 1 $0 4 Director 27 May 2022, 17:02
GNCA GENOCEA BIOSCIENCES, INC. 24 May 2022 2 -$750,662 4 10%+ Owner 26 May 2022, 18:32
TRVI Trevi Therapeutics, Inc. 11 Apr 2022 3 $12,499,999 4 10%+ Owner 13 Apr 2022, 17:29
BHG Bright Health Group Inc. 03 Jan 2022 2 $200,000,000 4 10%+ Owner 05 Jan 2022, 17:02
MTCR Metacrine, Inc. 10 Dec 2021 3 -$494,482 4 10%+ Owner 27 Dec 2021, 15:47
TRIL Trillium Therapeutics Inc. 17 Nov 2021 5 $0 4 Director 19 Nov 2021, 14:34
TRVI Trevi Therapeutics, Inc. 18 Oct 2021 3 $0 4 10%+ Owner 19 Oct 2021, 21:17
BHG Bright Health Group Inc. 28 Jun 2021 12 $34,999,992 4 10%+ Owner 30 Jun 2021, 21:33
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 7 $19,950,000 4 10%+ Owner 30 Jun 2021, 18:08
BHG Bright Health Group Inc. 24 Jun 2021 0 $0 3 10%+ Owner 24 Jun 2021, 21:33
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 10%+ Owner 23 Jun 2021, 21:14
ALLK Allakos Inc. 25 May 2021 1 $0 4 Director 14 Oct 2021, 16:52